New hydrogel drug delivery helps prevents transplant rejection
from By Lynn Hetzler
Clinicians currently use systemic immunosuppression in vascularized composite allotransplantation, or VCA. While VCA can be a superior method of restoring the function and aesthetics of transplants, it can also cause significant side effects and negatively affect the quality of life for transplant patients. Scientists have now developed a means to administer immunosuppressant drugs locally. Furthermore, the researchers found a way to package the immunosuppressant drugs to release medication only when prompted by inflammation.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063